Grade 3-4 cytopenias associated with dasatinib
| . | No. patients (%) at 8-mo follow-up . | |
|---|---|---|
| MBC-CML . | LBC-CML . | |
| Leukopenia | 47 (64) | 29 (69) |
| Neutropenia | 61 (82) | 33 (79) |
| Thrombocytopenia | 62 (84) | 37 (88) |
| Anemia | 50 (68) | 22 (52) |
| . | No. patients (%) at 8-mo follow-up . | |
|---|---|---|
| MBC-CML . | LBC-CML . | |
| Leukopenia | 47 (64) | 29 (69) |
| Neutropenia | 61 (82) | 33 (79) |
| Thrombocytopenia | 62 (84) | 37 (88) |
| Anemia | 50 (68) | 22 (52) |
For MBC-CML, n = 74; for LBC-CML, n = 42.